Short Topics

The short topics below are thirty minutes or less, and provided as an educational opportunity and resource for laboratory professionals. Our Spotlight series focuses on test utilization, new tests, and testing technologies topics.

*Please note: Our short topics do not provide continuing education credits.

Subscribe to our mailing list for the latest news regarding our educational opportunities
Click to Subscribe
Your information will not be shared externally.

Behind the Making of MLL:

Vision and Mission by
Professor Torsten Haferlach, MD, D.Phil

MLL 2.0 – From See Behind to Go Beyond

by
Professor Claudia Haferlach, MD

ASCP Histotechnician/Histotechnologist Exam Preparation

by
Derek Bradshaw, HTL (ASCP)

AACC 2019 Booth Presentation:

Back to Our Roots: The Healing Power of Ethical Business Strategies by
Brian R. Jackson, MD, MS

AACC 2019 Booth Presentation:

The True Life Story of Automating a Hospital Laboratory by
Jo D Fontenot, MS, MT(ASCP)

AACC 2019 Booth Presentation:

Defining the Downstream Impact of Laboratory Stewardship by
Andrew Fletcher, MD, MBA, CPE, CHCQM, FCAP

AACC 2019 Booth Presentation:

Harnessing the Power of Pharm/Lab Collaboration by
Danielle C. Kauffman, PharmD, MBA

Point of Care:

Leading the Way by
Jo D Fontenot, MS, MT(ASCP)

AACC 2017 Booth Presentation:

Advances in Viral Hepatitis Testing by
Patricia R. Slev, PhD, D(ABCC)

AACC 2017 Booth Presentation:

Earning Customer Loyalty Through Tough Love by
Brian R. Jackson, MD, MS

AACC 2017 Booth Presentation:

Inborn Errors of Metabolism—The Needle in the Haystack by
Irene De Biase, MD, PhD, FACMG

AACC 2017 Booth Presentation:

Inflammatory Myopathies— A Laboratory Update on Autoantibody Testing by
Anne E. Tebo, PhD

AACC 2016 Booth Presentation:

Three Critical Success Factors to Fuel Lab UM Programs by
Brian R. Jackson, MD, MS

AACC 2016 Booth Presentation:

Utilization Management and Beyond: The Many Roles of Genetic Counselors in the Lab by
Sara Brown, MS, LCGC

AACC 2016 Booth Presentation:

All the Right Technology in All the Right Places: The Necessary Evolution of Urine Drug Testing by
Frederick G. Strathmann, PhD, DABCC (CC, TC)

AACC 2016 Booth Presentation:

Molecular Detection of Gastrointestinal Pathogens by
Marc Roger Couturier, PhD, D(ABMM)

AACC 2015 Booth Presentation:

Cell-free DNA Tests for Non-invasive Prenatal Aneuploidy Screening by
David G. Grenache, PhD, MT(ASCP), DABCC

AACC 2015 Booth Presentation:

If Baby Could Talk: Laboratory Detection of Prenatal Drug Exposure by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

AACC 2015 Booth Presentation:

An Interferent No More: Measuring Thyroglobulin in the Presence of Anti-Thyroglobulin Autoantibodies by
Joely A. Straseski, PhD, MS, MT(ASCP), DABCC

AACC 2015 Booth Presentation:

Non-Invasive Assessment of Liver Fibrosis by
Patricia R. Slev, PhD, D(ABCC)

Test Utilization Study:

Vitamin D Utilization Management Study: An Overview of Results by
Robert Schmidt, MD, PhD, MBA
Joely A. Straseski, PhD, MS, MT(ASCP), DABCC

PainWeek 2014 Booth Presentation:

Making Sense of the Patterns: Is it Oxycodone or Not... and Other Compliance Interpretation Questions by
Frederick G. Strathmann, PhD, DABCC (CC, TC)

PainWeek 2014 Booth Presentation:

Understanding the Technology: Is Mass Spectrometry Really Better or Are Immunoassays Just Fine? by
Frederick G. Strathmann, PhD, DABCC (CC, TC)

AACC 2014 Booth Presentation:

Extreme Makeover: Lab Edition by
Brian R. Jackson, MD, MS

AACC 2014 Booth Presentation:

How Automation is Necessary to Achieve Six-Sigma Quality by
Charles D. Hawker, PhD, MBA, FACSc, FAACC, FACB

AACC 2014 Booth Presentation:

How to Estimate the Impact of Changing Laboratory Methods by
Robert Schmidt, MD, PhD, MBA

AACC 2014 Booth Presentation:

Risk Stratification in Heart Failure - The Role of Emerging Biomarkers by
David G. Grenache, PhD, MT(ASCP), DABCC

Painweek 2013 Booth Presentation:

The Clinical Utility of Pharmacogenetic Testing in Pain Management by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

Painweek 2013 Booth Presentation:

What’s in a Number? Can Quantitative Drug Testing Results Be Used to Delineate Partial vs. Full Dose Compliance by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

AACC 2013 Booth Presentation:

Children Aren't Small Adults! (and Other Pediatric Reference Interval Challenges) by
Joely A. Straseski, PhD, MS, MT(ASCP), DABCC

AACC 2013 Booth Presentation:

What’s in a Number? Can Quantitative Drug Testing Results Be Used to Delineate Partial vs. Full Dose Compliance by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

AACC 2013 Booth Presentation:

A Hippocratic Oath for the Diagnostics Industry by
Brian R. Jackson, MD, MS

AACC 2013 Booth Presentation:

Why Labs Request Clinical Information: Examining the Impact on Patient Care by
Elaine Lyon, PhD

Test Utilization:

Appropriate Utilization of Drug Tests for Pain Management Patients by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

Painweek 2012 Booth Presentation:

Strategies to Detect and Prevent Adulteration and Substitution in Urine Drug Testing by
Kamisha L. Johnson-Davis, PhD, DABCC (CC, TC), DABCC(CC, FAACC)

Painweek 2012 Booth Presentation:

Managing Costs Associated With Chronic Pain by Early Detection of Nonadherence and Cost-conscious Urine Drug Monitoring by
Gordon Nelson, C(ASCP), NRCC-TC

AACC 2012 Booth Presentation:

Roles of the Clinical Laboratory in Pain Management by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

AACC 2012 Booth Presentation:

Utility of Anti-Müllerian Hormone as a Marker of Ovarian Reserve by
Joely A. Straseski, PhD, MS, MT(ASCP), DABCC

AACC 2012 Booth Presentation:

Analysis Approaches for the Clinical Exome by
Elaine Lyon, PhD

AACC 2012 Booth Presentation:

Gastrointestinal Polyposes and Cancer Syndromes: Pathologic and Genetic Diagnosis by
Mary Bronner, MD

Test Utilization:

Improving Ordering Practices for the Diagnosis of Helicobacter pylori by
Marc Roger Couturier, PhD, D(ABMM)

APS 2012 Booth Presentation:

A Novel Approach to Drug Screening With Blood by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

APS 2012 Booth Presentation:

Cost-effective Utilization of Urine Drug Testing for Chronic Pain Management Patients by
Gordon Nelson, C(ASCP), NRCC-TC

APS 2012 Booth Presentation:

Patterns of Opioid Metabolites in Urine - The Buprenorphine Story by
Gwendolyn A. McMillin, PhD, DABCC(CC, TC)

Test Utilization:

The Changing Landscape of Fetal Lung Maturity Testing by
David G. Grenache, PhD, MT(ASCP), DABCC

Test Utilization:

Inherited Thrombophilia Testing: Pros and Cons by
George M. Rodgers III, MD, PhD
Kristi J. Smock, MD